MEIS-1 level in unresectable hepatocellular carcinoma can predict the post-treatment outcomes of radiofrequency ablation

Radiofrequency ablation (RFA) is a local-ablative therapy for unresectable hepatocellular carcinoma (HCC). At present, there is no predictive marker for RFA treatment outcomes. This work aimed to valuate myeloid ecotropic viral integration site 1 (MEIS-1) in predicting post-RFA treatment outcomes of...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Hui, Yu, Haipeng, Tian, Shengtao, Yang, Xueling, Wang, Ximing, Wang, Huaming, Guo, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880601/
https://www.ncbi.nlm.nih.gov/pubmed/29632641
http://dx.doi.org/10.18632/oncotarget.24165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880601/
https://www.ncbi.nlm.nih.gov/pubmed/29632641
http://dx.doi.org/10.18632/oncotarget.24165

Ejemplares similares